Skip to main content

Table 2 Clinical outcomes and relevant medication therapy

From: Quetiapine in refractory hyperactive and mixed intensive care delirium: a case series

Outcomes Median pre-quetiapine days, n(range) Median post-quetiapine days, n(range)
Duration of refractory delirium 15 (3 to 48) 4 (2 to 29)
Duration of ventilatory support 20.5 (1 to 58) 11 (3 to 17)
Duration of ventilatory support since RASS score 0 achieved - 2 (1 to 11)
Haloperidol n = 14 6 (1 to 37) 0.5 (0 to 7)
Lorazepam, n = 10 9.5 (1 to 19) 1 (0 to 7)
Propofol, n = 17 17 (5 to 27) 6 (0 to 18)
Opioids (fentanyl/alfentanil), n = 17 18 (7 to 34) 0 (0 to 16)
Clonidine, n = 14 9.5 (2 to 33) 2 (0 to 16)